Skip to main content
EVGN
NASDAQ Industrial Applications And Services

Selling Shareholder Offers 2.45M Shares Amidst Delisting Concerns

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.71
Mkt Cap
$9.005M
52W Low
$0.7
52W High
$2.42
52W Position info
1.5% above low
Off High info
71% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

EVGN is trading near its 52-week low of $0.7 (1.5% above the low).

Summary

A selling shareholder is offering 2.45 million shares, valued at approximately $1.8 million, representing 20% of Evogene's market cap, intensifying pressure on the distressed company already facing delisting and going concern doubts.


Key Events · Financing and Capital Events · EVGN

  • Significant Share Resale

    A selling shareholder is offering 2,446,707 ordinary shares. Based on the last reported sale price of $0.74 per share (May 19, 2026), this offering is valued at approximately $1.8 million, representing about 20% of the company's current market capitalization.

  • No Proceeds to Company

    The company will not receive any proceeds from the sale of these shares, as they are being offered by an existing shareholder.

  • Distressed Company Context

    This significant offering occurs while Evogene is trading near its 52-week low, faces a Nasdaq delisting notice, and has disclosed substantial doubt about its ability to continue as a going concern. The company also recently reported a wider net loss and lower revenue in Q1 2026.


Analysis · EVGN · Industrial Applications And Services

A selling shareholder is offering 2.45 million ordinary shares, valued at approximately $1.8 million, which represents a substantial 20% of Evogene's current market capitalization. This significant increase in market supply from an institutional investor adds considerable selling pressure and market overhang, particularly as the company is already facing Nasdaq delisting, has expressed substantial doubt about its ability to continue as a going concern, and recently reported a wider net loss and lower revenue in Q1 2026. The company will not receive any proceeds from this resale.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EVGN was trading at $0.71 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9M. The 52-week trading range was $0.70 to $2.42. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EVGN - Latest Insights

EVGN
Nov 19, 2026, 7:12 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.3233
Real-time Price: $0.313 info
Change: -$0.0103 (-3%) info
Market Cap: $5.708M info
EVGN
Nov 16, 2026, 7:01 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3646
Real-time Price: $0.313 info
Change: -$0.0516 (-14%) info
Market Cap: $5.708M info
EVGN
Oct 06, 2026, 4:00 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.4101
Real-time Price: $0.313 info
Change: -$0.0971 (-24%) info
Market Cap: $5.708M info
EVGN
Sep 30, 2026, 7:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4168
Real-time Price: $0.313 info
Change: -$0.1038 (-25%) info
Market Cap: $5.708M info
EVGN
Sep 28, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3907
Real-time Price: $0.313 info
Change: -$0.0777 (-20%) info
Market Cap: $5.708M info